HeartSciences (HSCS) Other Accumulated Expenses (2022 - 2025)

HeartSciences' (HSCS) quarterly Other Accumulated Expenses came in at $29927.0 in Q4 2025, down 79.86% on a QoQ basis from $148572.0 in Q4 2025.

HeartSciences (HSCS) Other Accumulated Expenses (2022 - 2025) Analysis & Trends

HeartSciences (HSCS) has 4 years of Other Accumulated Expenses data on file, last reported at $29927.0 in Q4 2025.

Quarterly Other Accumulated Expenses changed N/A year-over-year to $29927.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $29927.0 (changed N/A YoY) and the FY2025 annual result came in at $29927.0, down 12.36% from the prior year.
Other Accumulated Expenses slipped to $29927.0 in Q4 2025, from $148572.0 in the prior quarter.
In the past five years, Other Accumulated Expenses ranged from a high of $389186.0 in Q3 2022 to a low of $1220.0 in Q2 2022.
A 4-year average of $148062.4 and a median of $153596.0 in 2023 frame the typical range for Other Accumulated Expenses.
The widest YoY moves for Other Accumulated Expenses: up 3883.28% in 2023, down 45.62% in 2023.
Tracing HSCS's Other Accumulated Expenses over 4 years: stood at $291670.0 in 2022, then plunged by 45.62% to $158620.0 in 2023, then rose by 9.47% to $173644.0 in 2024, then tumbled by 82.77% to $29927.0 in 2025.
The last three Other Accumulated Expenses figures came in at $29927.0 (Q4 2025), $148572.0 (Q4 2025), and $215334.0 (Q3 2025), per Business Quant data.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Abbott Laboratories	198.70 Bn	193.10 Bn	7.27 Bn
2	Stryker	125.85 Bn	122.37 Bn	4.50 Bn
3	Medtronic	118.44 Bn	109.22 Bn	6.41 Bn
4	Boston Scientific	72.64 Bn	72.10 Bn	3.85 Bn
5	Edwards Lifesciences	51.94 Bn	47.69 Bn	1.35 Bn
6	Dexcom	34.48 Bn	32.53 Bn	830.00 Mn
7	GE HealthCare Technologies	33.60 Bn	31.49 Bn	2.18 Bn
8	Koninklijke Philips	26.30 Bn	22.98 Bn	4.55 Bn
9	Steris	23.00 Bn	22.52 Bn	684.20 Mn
10	HeartSciences	6.54 Mn	4.84 Mn	-

Download Data